• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Achillion Pharmaceuticals, Inc. (ACHN)

    -NasdaqGS
    14.55 0.35(2.43%) Dec 18, 4:00PM EST
    Add to Portfolio
    Prev Close:14.20
    Open:14.81
    Bid:14.31 x 100
    Ask:14.86 x 900
    1y Target Est:13.38
    Beta:2.18
    Earnings Date:Mar 5 - Mar 9 (Est.)
    Day's Range:14.28 - 14.95
    52wk Range:2.45 - 15.31
    Volume:4,456,319
    Avg Vol (3m):5,703,900
    Market Cap:1.46B
    P/E (ttm):N/A
    EPS (ttm):-0.62
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ACHNUp 2.43%1.46B
    GSK104.07B
    JNJ298.97B
    RHHBY250.73B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.66
    Quarterly EPS Est (Dec-14) :-0.18
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-1.13

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback